Corrigendum: Combination therapy with fingolimod and neural stem cells promotes functional myelination in vivo through a non-immunomodulatory mechanism

Front Cell Neurosci. 2022 Dec 15:16:1022297. doi: 10.3389/fncel.2022.1022297. eCollection 2022.

Yuan Zhang^{1

2}, Xin-Yu Lu², Ze-Qin Ye², Bogoljub Ciric¹, Cun-Gen Ma³, Abdolmohamad Rostami¹, Xing Li^{1

2}, Guang-Xian Zhang¹

¹ Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States.
² National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, Shaanxi Normal University, Xi'an, China.
³ Department of Neurology, Institute of Brain Science, Shanxi Datong University Medical School, Datong, China.

Abstract

[This corrects the article DOI: 10.3389/fncel.2019.00014.].

Keywords: combination therapy; fingolimod; myelination; neural stem cells; oligodendrocytes.